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ORIGINAL ARTICLE
The field of nitric oxide (NO) measurement has
developed rapidly in recent decades. The frac-
tional concentration of exhaled NO (FENO) has
been reported to be elevated in many lung diseases
including asthma, atopy, upper airway viral infec-
tions,1 post-transplant lung rejection,2 radiation
pneumonitis,3 and fibrosing alveolitis.4 Several
factors can influence the level of FENO in normal
individuals, including digested L-arginine or 
nitrate-containing food, physical exercise, cigarette
smoking, and alcohol consumption.5 To reduce
the variation in results among studies using dif-
ferent measurement techniques, the European
Respiratory Society (ERS) and American Thoracic
Society (ATS) published their recommendations
for standardized measurement of exhaled NO
and nasal NO in 2005.6
Some studies have shown that FENO measure-
ment is a useful noninvasive marker of airway 
inflammation.7,8 It can also be applied to the
treatment of chronic asthma.9,10 Other studies
have suggested that measuring FENO is a safe and
rapid diagnostic test for asthma.11,12 To date, how-
ever, there have only been a few studies on refer-
ence values and determinants of FENO in healthy
adults.13–16 Therefore, we investigated reference
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Background/Purpose: The fractional concentration of exhaled nitric oxide (FENO) has been reported to 
be elevated in asthma and many other lung diseases. The present study investigated reference values and
determinants of FENO in a Taiwanese non-smoking, healthy adult population.
Methods: We used a chemiluminescence analyzer according to American Thoracic Society/European
Respiratory Society recommendations to measure FENO values in 356 adults who received a health check-up
and a detailed respiratory questionnaire at Taichung Veterans General Hospital, Taiwan. Among the vol-
unteers, 249 fulfilled our definition of healthy adults: no history of smoking or physician-diagnosed asthma;
no recent upper airway infection; no chronic respiratory symptoms; and no allergic rhinitis and urticaria.
Results: Among the 249 non-smoking and non-asthmatic adults, the mean (5th to 95th percentile refer-
ence range) FENO was 27.9 (12.5–58.0) parts per billion. In multivariate regression analyses, age and lung
function (forced vital capacity or forced expiratory volume in 1 second) were associated positively with FENO
values. Sex, height, weight, and ambient NO values were not associated significantly with FENO values.
Conclusion: Age and lung function were predictors of FENO in this population, and these factors should be
considered for clinical applications of FENO measurements. [J Formos Med Assoc 2009;108(10):772–777]
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values and determinants for FENO in a popula-
tion who received a general health check-up at
Taichung Veterans General Hospital, Taiwan.
Patients and Methods
Subjects and protocol
This study was approved by the Institutional
Review Board of the hospital. We recruited vol-
unteers who received a general health check-up
at Taichung Veterans General Hospital in Taiwan.
Adults aged > 20 years were recruited after they
had given written informed consent. All subjects
finished a detailed questionnaire about personal
medical history, smoking history, atopic history,
recent upper airway infection, wheezing, and
chronic cough. All subjects were asked to fast for
at least 12 hours before the health check-up. FENO
measurements were performed on all volunteers
before they received a routine health check-up 
in the morning. Spirometry was done after FENO
measurement. A total of 356 subjects completed
the measurements, but only 249 fulfilled our def-
inition of healthy adults. We excluded subjects
who had a smoking history, physician-diagnosed
asthma, recent upper airway infection (onset
within the previous 2 weeks), chronic respiratory
symptoms (e.g. chronic cough, productive cough,
or wheezing), and atopic history. The definition
of atopic history was physician-diagnosed aller-
gic rhinitis, urticaria, or recurrent symptoms of
rhinitis or skin allergy.
Measurement of FENO
FENO was measured online by a chemilumines-
cence analyzer (NOA* 280i System; Sievers,
Boulder, CO, USA) according to the most recent
ATS/ERS recommendations.6 The seated subjects
inhaled ambient air to total lung capacity. With a
tube attached to their mouth, they exhaled slowly
using an assistance device to maintain a constant
flow rate of 50 mL/second. The ambient NO val-
ues were recorded simultaneously during each
test. The plateau concentration of FENO, which
was sustained for at least 3 seconds, was recorded 
automatically by the NO analyzer. Repeated, re-
producible exhalations were performed until three
plateau values came to within a 10% variation of
each other. The valid value of FENO was recorded
as the mean of these three plateau values.
Statistical analysis
All geometric data from the 249 non-smoking
healthy adults were collected. The reference values
of FENO in parts per billion (ppb) were presen
ted as the geometric mean with a reference range
between the 5th and 95th percentile values. The
univariate analyses between individual variables
and FENO values were based on Kruskal–Wallis,
Mann–Whitney U and independent t tests, ac-
cording to different situations. As a result of the
skewed distribution of FENO values, they were
transformed to natural logarithms, and models
of multivariate linear regression analysis were
performed stepwise to determine the explanatory
variables. These variables included sex, age, body
height and weight, lung function [absolute forced
vital capacity (FVC) or forced expiratory volume
in 1 second (FEV1)], and ambient NO values. A
value of p < 0.05 was taken as statistically signifi-
cant. The analyses were performed using the SPSS
Rel. 12.0 statistical package (SPSS Inc., Chicago,
IL, USA).
Results
A total of 249 non-smoking healthy adults were
enrolled prospectively from September 2006 to
March 2007. Table 1 presents the demographic
characteristics of the study population. There was
a significant difference in body height and weight,
FVC, and FEV1, but not age or ambient NO values,
between the male and female groups. The mean
(5th to 95th percentile) FENO was 29.9 (13.1–68.9)
ppb in the male group, 25.5 (11.9–51.8) ppb in
the female group, and 27.9 (12.5–58.0) ppb in
all subjects (Table 1). In the univariate analyses
(Table 2), FENO was significantly higher in the male
than the female group (p = 0.006). FENO differed
significantly between groups with different height
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Table 1. Demographic data and fractional concentration of exhaled nitric oxide (FENO) values among 249
healthy subjects*
Male (n = 134) Female (n = 115) All subjects (n = 249) p
Age (yr) 45.4 ± 13.3 45.0 ± 10.8 45.3 ± 12.2 0.744‡
Height (cm) 169.2 ± 5.4 157.8 ± 5.4 163.9 ± 7.8 < 0.001‡
Weight (kg) 69.7 ± 8.7 55.9 ± 8.1 63.3 ± 10.9 < 0.001‡
FVC (L) 4.1 ± 0.8 3.0 ± 0.5 3.6 ± 0.8 < 0.001§
FEV1 (L) 3.4 ± 0.7 2.5 ± 0.4 3.0 ± 0.7 < 0.001§
Ambient NO (ppb) 5.4 ± 6.3 5.4 ± 6.1 5.4 ± 6.2 0.804‡
FENO (ppb) 29.9 ± 16.5 (13.1–68.9)† 25.5 ± 15.4 (11.0–51.8)† 27.9 ± 16.1 (12.5–58.0)† 0.006‡
ln FENO 3.3 ± 0.5 (2.6–4.2)† 3.1 ± 0.5 (2.4–4.0)† 3.2 ± 0.5 (2.5–4.1)† 0.006‡
*Data are presented as mean ± standard deviation; †5th to 95th percentile; ‡Mann–Whitney U test; §independent t test. FVC = forced
vital capacity; FEV1 = forced expiratory volume in 1 second; ppb = parts per billion.




Mean ± SD 5th to 95th percentile
Sex 0.006*
Female 25.5 ± 15.4 11.0–51.8
Male 29.9 ± 16.5 13.1–68.9
Ambient NO (ppb) 0.641*
< 5 28.4 ± 16.8 13.1–64.3
≥ 5 26.8 ± 14.7 11.0–51.8
Age (yr) 0.074†
< 30 24.5 ± 13.5 9.6–54.7
30–39 31.7 ± 24.3 9.4–89.8
40–49 26.4 ± 13.1 13.0–55.3
50–59 28.1 ± 15.6 12.1–49.6
≥ 60 32.3 ± 14.9 18.2–70.5
Height (cm) 0.045†
< 155 24.0 ± 9.3 11.6–42.6
155–164 26.3 ± 16.4 11.0–54.6
165–174 31.2 ± 17.7 13.5–74.3
≥ 175 27.88 ± 13.9 16.4–124.0
Weight (kg) 0.013†
< 50 24.5 ± 10.6 13.6–48.8
50–59 24.8 ± 16.9 9.4–51.8
60–69 30.2 ± 17.0 13.1–64.3
≥ 70 29.7 ± 15.9 15.4–68.9
*Mann–Whitney U test; †Kruskal–Wallis test.
and weight. After all variables were included for
multivariate regression analysis with the natural
logarithm of FENO, only age and FVC were signi-
ficant variables for FENO (Table 3). Sex, body
height and weight, and ambient NO were not
significantly associated with FENO (Table 3). Similar
associations for age and lung function were still
observed in the multivariate regression model
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when FVC was substituted for FEV1 (data not
shown).
Discussion
The main result of our study was that age and
lung function were associated positively with
FENO values in this adult population. Conversely,
sex, body height and weight, and ambient NO
were not significantly associated with FENO when
other variables were controlled. The association
between sex and FENO has been reported in several
previous studies.13–15,17,18 In a study by Olivieri
et al,15 multivariate analysis was done on a sam-
ple of 204 healthy non-smoking young adults,
and the results showed that male sex was associ-
ated positively with FENO. A random community
survey of adults by Travers et al14 showed that
male sex and atopy predicted an increase in FENO.
In our univariate analyses, male subjects had in-
creased FENO. However, the contribution of sex
was not significant when sex and other covariates
were included in the model of multivariate re-
gression analysis. Therefore, we conclude that sex
is not associated with FENO, and this is similar to
a study in a large adult population by Olin et al.16
Although the influence of lung function has
not been described clearly in previous studies, it
was a significant predictor for FENO in the pres-
ent study. This finding does not agree with that
of Olivieri et al,15 who showed that FENO is not
associated with lung function. Malmberg et al
performed a study in 114 healthy non-atopic
school-age children,19 which revealed that FENO
is associated with FEV1 and FVC in liters, but 
not when lung function is expressed as percent
predicted. The same association of absolute lung
function and log-transformed FENO has also been
noted by Kovesi et al.20 The absolute FVC and
FEV1 values can indicate lung size more ration-
ally than a percentage of predicted values. The
percent values are more likely to present under-
lying lung disease. Hence, we selected absolute
lung function values instead of percent values as
the explanatory variables for FENO. Why does pul-
monary function influence FENO? The nature of
flow-dependent FENO values has been reported in
several studies,21–23 which means that measure-
ment at a lower expiratory flow rate has a relatively
higher FENO value in the same subject. If the flux
of NO from the airway mucosa were constant,
lower flow rate would prolong air transit time in
the airway and hence produce higher FENO values.
If both subjects have the same exhaled flow rate,
it is speculated that subjects with large airway 
diameter may have a relatively lower flow rate in
their peripheral airway when compared with
subjects with small airway diameter. It is known
that subjects with higher FVC and FEV1 indicate
they have larger airway size when compared with
others. Thus, the hypothesis of flow-dependence
could explain why FVC and FEV1 were positively
associated with FENO values in the present study.
On the other hand, it could explain why men had
higher FENO values than women in the univariate
analyses. However, sex was no longer a signifi-
cant factor when FVC or FEV1 was controlled for
in the multivariate regression analysis model.
Several studies have noted that age is a predictor
of FENO in children.20,24 However, the influence
of age is controversial in adult studies. Olivieri 
et al15 and Travers et al14 have found that age is
not a predictor of FENO. Our results have revealed
that age is a predictor of FENO in adults, which is
in agreement with the findings of Olin et al.25
The reason why FENO is associated positively with
age in healthy subjects is not clear.
Table 3. Multivariate regression analyses for
natural logarithm of fractional
concentration of exhaled nitric oxide
(FENO) among 249 healthy subjects
Coefficients Standard error p
Intercept 3.056 1.070 0.005
Height −0.006 0.008 0.424
Weight 0.003 0.004 0.514
Sex* 0.020 0.098 0.842
Age 0.008 0.003 0.005
FVC 0.166 0.064 0.010
Ambient NO −0.031 0.065 0.639
*0 = female, 1 = male. Adjusted R2 = 0.056. FVC = forced vital
capacity.
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An association between body height and FENO
in adults has been reported by Olin et al.25 In
our study, FENO values were associated with body
height and weight in the univariate analyses, but
the association was not significant when other
variables such as lung function were considered
in the multivariate regression analysis. Therefore,
we speculate that lung size, instead of body size,
plays a more important role in affecting FENO
values.
Although there is evidence that ambient NO
does not affect the FENO values from a single-
breath plateau curve,21,26 the influence of ambient
NO on measurement of FENO is controversial. 
In our study, we considered the discomfort and
infection concern of our volunteers when they
received test and inspired NO-free air from the
NO-scrubbing filter. Then, we used ambient air
as the inspired gas source and recorded ambient
NO and FENO values simultaneously during each
test. We also analyzed the influence of ambient
NO on FENO values. The results from multivariate
regression analyses in our healthy adults revealed
that ambient NO was not a significant variable
for FENO measurement.
The mean (5th to 95th percentile) value of FENO
in our population of healthy adults was 29.8
(12.5–58.0) ppb. Olivieri et al reported mean (5th
to 95th percentile) values for FENO of 11.7 (4.5–
20.6) ppb for men and 9.9 (3.6–18.2) ppb for
women, in a sample of healthy non-smoking
adults with a relatively young age (mean, 36.1
years).15 Olin et al reported a mean (95% confi-
dence interval) FENO value of 16.6 (5.9–47.1) ppb
in a sample of non-smoking and non-asthmatic
adults.16 When comparing our data with these
two studies, the reference values for FENO in our
healthy subjects seemed higher. Although the
methods used in the previous studies were the
same as ours, according to the 2005 ATS/ERS 
recommendations, there were some factors that
could have been involved in addition to method-
ological factors. In a study by Wong et al,27 which
enrolled 258 Chinese and 33 Caucasian school
children in Hong Kong, healthy Chinese children
had significantly higher FENO values than healthy
Caucasian children. Kovesi et al also found that
Asian–Canadian children have significantly higher
FENO values than Caucasian children.20 The mean
(95% confidence interval) values for FENO were
22.8 (17.9–27.7) ppb in Asian–Canadian chil-
dren and 12.7 (11.8–13.7 ppb) ppb in Caucasian
children.20 Lund et al enrolled 377 adult twins
and analyzed the variation in FENO and airway
responsiveness.28 They concluded that genetic fac-
tors accounted for most variation in FENO, while
non-shared environmental factors explained the
remaining variation. Therefore, we speculate that
ethnic factors were one of the explanations for our
higher FENO values in healthy Taiwanese adults.
Confirmation of the role of ethnic factors in FENO
value variation requires further studies on genetic
and environmental factors.
The regression equation in Table 3 explains
only about 5.6% of the variance in the FENO val-
ues. Here, we did not present the reference ranges
according to age and lung function as in previous
studies, because of their low predictability and
accuracy. There seem to have been unconfirmed
factors that caused the variation in FENO values.
Some studies have speculated that subclinical
airway inflammation, environmental exposure,
nutrition, and genetic factors are confounding
factors in the variation in FENO values.29–31 The
influence of nitrite-rich food was low in our study
because we advised our volunteers to avoid this
and fast for at least 12 hours before FENO mea-
surement.32 Kharitonov et al reported that recent
upper airway infection can elevate the baseline
level of FENO.1 Therefore, we excluded subjects
who had evidence of upper airway infection within
the previous 2 weeks, to lower the confounding
factors in our study.
In conclusion, to the best of our knowledge,
the present study demonstrated that age and lung
function were positively associated with FENO val-
ues in a Taiwanese population of non-smoking
healthy adults. To date, however, the reasons for age
differences are not clear. The positive association
between lung function and FENO may have been
the result of the influence of lung size. Ethnic dif-
ferences need to be investigated by further large
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studies in populations of different races. We hope
that our findings will pave the way for further
studies of FENO measurement.
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